These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
388 related articles for article (PubMed ID: 32240615)
1. 1,25(OH) Liu P; Li F; Xu X; Li S; Dong X; Chen L; Bai B; Wang Y; Qiu M; Dong Y Exp Mol Pathol; 2020 Jun; 114():104434. PubMed ID: 32240615 [TBL] [Abstract][Full Text] [Related]
2. Expression and cellular distribution of TLR4, MyD88, and NF-κB in diabetic renal tubulointerstitial fibrosis, in vitro and in vivo. Liu P; Li F; Qiu M; He L Diabetes Res Clin Pract; 2014 Aug; 105(2):206-16. PubMed ID: 24894085 [TBL] [Abstract][Full Text] [Related]
3. Liraglutide ameliorates inflammation and fibrosis by downregulating the TLR4/MyD88/NF-κB pathway in diabetic kidney disease. Huang L; Lin T; Shi M; Wu P Am J Physiol Regul Integr Comp Physiol; 2024 Oct; 327(4):R410-R422. PubMed ID: 39133777 [TBL] [Abstract][Full Text] [Related]
4. 1,25(OH)2D3 downregulates the Toll-like receptor 4-mediated inflammatory pathway and ameliorates liver injury in diabetic rats. Wang H; Zhang Q; Chai Y; Liu Y; Li F; Wang B; Zhu C; Cui J; Qu H; Zhu M J Endocrinol Invest; 2015 Oct; 38(10):1083-91. PubMed ID: 25906757 [TBL] [Abstract][Full Text] [Related]
5. 1,25(OH)2D3-mediated amelioration of aortic injury in streptozotocin-induced diabetic rats. Li F; Liu P; Zhang X; Zhang Q; Tang S; Zhu M; Qiu M Inflammation; 2013 Dec; 36(6):1334-43. PubMed ID: 23813327 [TBL] [Abstract][Full Text] [Related]
6. Atorvastatin reduces contrast media-induced pyroptosis of renal tubular epithelial cells by inhibiting the TLR4/MyD88/NF-κB signaling pathway. Yue RZ; Li YJ; Su BH; Li CJ; Zeng R BMC Nephrol; 2023 Feb; 24(1):25. PubMed ID: 36732683 [TBL] [Abstract][Full Text] [Related]
7. Tanshinone IIA prevents left ventricular remodelling via the TLR4/MyD88/NF-κB signalling pathway in rats with myocardial infarction. Wu DM; Wang YJ; Han XR; Wen X; Li L; Xu L; Lu J; Zheng YL J Cell Mol Med; 2018 Jun; 22(6):3058-3072. PubMed ID: 29524303 [TBL] [Abstract][Full Text] [Related]
8. The role of Toll-like receptor 4 in high-glucose-induced inflammatory and fibrosis markers in human peritoneal mesothelial cells. Choi SY; Ryu HM; Choi JY; Cho JH; Kim CD; Kim YL; Park SH Int Urol Nephrol; 2017 Jan; 49(1):171-181. PubMed ID: 27722989 [TBL] [Abstract][Full Text] [Related]
9. Umbelliferone ameliorates renal function in diabetic nephropathy rats through regulating inflammation and TLR/NF-κB pathway. Wang HQ; Wang SS; Chiufai K; Wang Q; Cheng XL Chin J Nat Med; 2019 May; 17(5):346-354. PubMed ID: 31171269 [TBL] [Abstract][Full Text] [Related]
10. Lysophosphatidic acid receptor 1 inhibitor, AM095, attenuates diabetic nephropathy in mice by downregulation of TLR4/NF-κB signaling and NADPH oxidase. Lee JH; Sarker MK; Choi H; Shin D; Kim D; Jun HS Biochim Biophys Acta Mol Basis Dis; 2019 Jun; 1865(6):1332-1340. PubMed ID: 30763641 [TBL] [Abstract][Full Text] [Related]
11. Zhilong Huoxue Tongyu Capsule attenuates hemorrhagic transformation through the let-7f/TLR4 signaling pathway. Geng L; Zheng LZ; Kang YF; Pan CL; Wang T; Xie C; Liang B; Liao HL J Ethnopharmacol; 2023 Aug; 312():116521. PubMed ID: 37080368 [TBL] [Abstract][Full Text] [Related]
12. Cardioprotective role of GTS-21 by attenuating the TLR4/NF-κB pathway in streptozotocin-induced diabetic cardiomyopathy in rats. Youssef ME; Abdelrazek HM; Moustafa YM Naunyn Schmiedebergs Arch Pharmacol; 2021 Jan; 394(1):11-31. PubMed ID: 32776158 [TBL] [Abstract][Full Text] [Related]
13. Berberine ameliorates diabetic nephropathy by inhibiting TLR4/NF-κB pathway. Zhu L; Han J; Yuan R; Xue L; Pang W Biol Res; 2018 Mar; 51(1):9. PubMed ID: 29604956 [TBL] [Abstract][Full Text] [Related]
14. Effect of Clostridium perfringens type C on TLR4/MyD88/NF-κB signaling pathway in piglet small intestines. Shi H; Huang X; Yan Z; Yang Q; Wang P; Li S; Sun W; Gun S Microb Pathog; 2019 Oct; 135():103567. PubMed ID: 31163250 [TBL] [Abstract][Full Text] [Related]
15. Oridonin protects against the inflammatory response in diabetic nephropathy by inhibiting the TLR4/p38-MAPK and TLR4/NF-κB signaling pathways. Li J; Bao L; Zha D; Zhang L; Gao P; Zhang J; Wu X Int Immunopharmacol; 2018 Feb; 55():9-19. PubMed ID: 29207360 [TBL] [Abstract][Full Text] [Related]
16. The regulatory effect of oxymatrine on the TLR4/MyD88/NF-κB signaling pathway in lipopolysaccharide-induced MS1 cells. Lu M; Zhang Q; Chen K; Xu W; Xiang X; Xia S Phytomedicine; 2017 Dec; 36():153-159. PubMed ID: 29157809 [TBL] [Abstract][Full Text] [Related]
17. Bergenin ameliorates diabetic nephropathy in C57BL/6 J mice by TLR4/MyD88/NF-κB signalling pathway regulation. Quan Y; Su P; Shangguan C; Hao H; Yue L; Chen C Toxicol Appl Pharmacol; 2023 Sep; 475():116633. PubMed ID: 37482253 [TBL] [Abstract][Full Text] [Related]
18. Role of TLR4/MyD88/NF-κB signaling in heart and liver-related complications in a rat model of type 2 diabetes mellitus. Tian J; Zhao Y; Wang L; Li L J Int Med Res; 2021 Mar; 49(3):300060521997590. PubMed ID: 33787393 [TBL] [Abstract][Full Text] [Related]
19. Phillygenin inhibits LPS-induced activation and inflammation of LX2 cells by TLR4/MyD88/NF-κB signaling pathway. Hu N; Wang C; Dai X; Zhou M; Gong L; Yu L; Peng C; Li Y J Ethnopharmacol; 2020 Feb; 248():112361. PubMed ID: 31683033 [TBL] [Abstract][Full Text] [Related]
20. Glabridin attenuates atopic dermatitis progression through downregulating the TLR4/MyD88/NF-κB signaling pathway. Chang J; Wang L; Zhang M; Lai Z Genes Genomics; 2021 Aug; 43(8):847-855. PubMed ID: 34021857 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]